GlassScriptPhysician profile
Jordy Cox
NPI 1295833457
$16,662.81
in general payments reported to CMS, 2019-2025
27 companies · $4,356 in 2025
The $4,356 reported for 2025 was more than what 80% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.86 · 2020: $199 · 2021: $206 · 2022: $11K · 2023: $494 · 2024: $850 · 2025: $4,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,853 · Travel and Lodging: $2,740 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,852.84 |
| Travel and Lodging | $2,739.65 |
| Education | $107.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,371.48 | 2022-2024 | Da Vinci Surgical System |
| Abiomed | $2,255.11 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,529.40 | 2024-2025 | Advantagerib, Ribfix Titan, Sternalock 360 System |
| Medtronic, INC. | $1,286.66 | 2021-2025 | Avalus, Ta, Endurant Iis |
| Endologix LLC | $633.80 | 2022-2023 | Alto Abdominal Stent Graft System |
| Edwards Lifesciences Corporation | $410.79 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $316.74 | 2020-2024 | |
| Davol INC. | $136.46 | 2025 | |
| Abbott Laboratories | $127.43 | 2025 | Epic, Sjm Regent |
| Atricure, INC. | $79.45 | 2023-2024 | |
| Pfizer INC. | $77.27 | 2022-2024 | |
| Cvrx, INC. | $76.89 | 2021-2023 | Barostim Neo System |
| Lsi Solutions INC | $64.32 | 2025 | Cor-Knot |
| Abbvie INC. | $38.78 | 2022-2023 | Dalvance |
| Depuy Synthes Sales INC. | $38.59 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $23.05 | 2022 | |
| Boston Scientific Corporation | $22.83 | 2023 | |
| Grifols USA, LLC | $20.88 | 2024 | Prolastin-C Liquid |
| Baxter Healthcare | $19.58 | 2023 | Coseal |
| Active Medical, LLC | $19.58 | 2024 | |
| Bolton Medical INC | $18.98 | 2021 | |
| Inspire Medical Systems, INC. | $18.46 | 2024 | Inspire |
| Amarin Pharma, INC. | $16.61 | 2020 | |
| Merck Sharp & Dohme LLC | $16.15 | 2024 | Verquvo |
| Conmed Corporation | $14.80 | 2022 | |
| Medtronic Vascular, INC. | $14.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.32 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordy Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.